Activity Preview

Live

A Group-Based Approach To Medication Assisted Treatment For Opioid Use Disorders (Archived Webinar)

Activity Type:

  • On Demand


Release Date: 6/16/2015

Expiration Date: 12/31/2020

  • AMA PRA Category 1: 1
  • Participation: 1

Register

Overview

West Virginia has been particularly hard hit by the current opioid epidemic and consistently ranks as one of the top two states suffering from opioid overdose and addiction. We describe our experience in the evolution of a sustainable treatment program using buprenorphine in providing medical and psycho-educational groups that are chronologically tied together. This model, which also includesindividual counseling and twelve step participation, moves participants through three “stages” of treatment: Beginning, Intermediate, and Advanced. Since 2004 we have treated more than 2000 patients and currently are providing care for 400 patients on-site (including 30-35 pregnant patients) and another 40 patients via tele-buprenorphine clinics. Treatment is open ended and the average time in clinic is 33 months. We believe this model is highly effective in keeping patients therapeutically engaged and increasing the quality of life for those suffering from the disease of addiction.

Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. pcssnow.org

Pricing

  • General Member - Free
  • Resident-Fellow Member - Free
  • Non-Member - Free

Educational Objectives

  1. Briefly describe the opioid epidemic in West Virginia
  2. Discuss the historical development of the WV model of using group addiction treatment bup/nx
  3. Describe the components of the WV Model
  4. Identify the benefits of chronologically linking bup/nx treatment with addiction psychoeducational treatments using a group model
  5. Identify short term and long term challenges in using this model.

Target Audience

This program is designed for physicians who have a waiver to treat opioid dependence in an office-based setting and other interested clinicians.

Estimated Time to Complete

Estimated Duration: 1 hour
Program Begin Date: June 8, 2015
Program Review Date: November 1, 2018
Program End Date: December 31, 2020

How to Earn Credit

Complete each section of the course, including the CME quiz and evaluation. You will then be eligible to print either a Certificate of Credit for physicians or a Certificate of Attendance for non-physicians.

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Faculty

  • Carl Rollynn Sullivan III, MD. Professor and Vice-Chairman; Director, Addictions Programs, Department of Behavioral Medicine & Psychiatry, West Virginia University School of Medicine. Disclosure: Speaker’s bureau- Reckitt Benckiser until 2014

Program Planners

  • Andrew Saxon, M.D. Professor, Department of Psychiatry & Behavioral Sciences; Director, Addiction Psychiatry Residency Program, University of Washington; Director, Center of Excellence in Substance Abuse Treatment and Education (CESATE)VA Puget Sound Health Care System. Reports no financial relationships with commercial interests.
  • Beatrice Eld – Associate Director, Addiction Psychiatry, American Psychiatric Association. Reports no financial relationships with commercial interests.
  • John A. Renner, Jr., M.D. – Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.
  • Frances R. Levin, M.D. – Kennedy Leavy Professor of Psychiatry at Columbia University Medical Center; Director, Addiction Psychiatry Fellowship, New York Presbyterian Hospital; Director of Clinical and Educational Activities for the Division on Substance Abuse, New York State Psychiatric Institute. Disclosure: Consultant: Major League Baseball, Grant/Research Support: US World Med.

Program Reviewers

  • John A. Renner, Jr., M.D. – Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.

Hardware/Software Requirements

For PC users, we recommend using a computer that is running the most recent version of Microsoft Windows. For Macintosh users, we recommend using a computer that is running OS X or later. Although the presentations and website can be viewed on any browser, we suggest Google Chrome for PC users and the latest version of Firefox for Macintosh users. Make sure your computer's software and browsers are updated regularly for an optimal experience. Due to the media-rich content, we recommend viewing programs at a minimum screen resolution of 800 x 600 pixels, but preferably 1024 x 768 pixels.

For assistance: Contact pcssmat@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance.

Register